Immunopathogenesis and Novel Therapeutics Strategies of Systemic Lupus Erythematosus-Reference-Cited by-同舟云学术

Immunopathogenesis and Novel Therapeutics Strategies of Systemic Lupus Erythematosus

Published:2023-05-30 Issue:11 Volume:24 Page:9470
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Kotyla Przemysław¹^ORCID,Olesińska Marzena²^ORCID

Affiliation:

1. Department of Internal Medicine, Rheumatology and Clinical Immunology, Faculty in Katowice, Medical University of Silesia, 40-635 Katowice, Poland

2. Department of Connective Tissue Diseases, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, Poland

Abstract

Systemic lupus erythematosus is a chronic connective tissue disease of unknown origin and unpredictable course [...]

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

https://www.mdpi.com/1422-0067/24/11/9470/pdf

Reference8 articles.

1. First use of cenerimod, a selective s1p(1) receptor modulator, for the treatment of sle: A double-blind, randomised, placebo-controlled, proof-of-concept study;Hermann;Lupus Sci. Med.,2019

2. Long-term prognosis of patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: Cstar-pah cohort study;Qian;Eur. Respir. J.,2019

3. Cathepsin s promotes the development of pulmonary arterial hypertension;Chang;Am. J. Physiol.-Lung Cell. Mol. Physiol.,2019

4. Szabó, K., Jámbor, I., Pázmándi, K., Nagy, N., Papp, G., and Tarr, T. (2022). Altered circulating follicular t helper cell subsets and follicular t regulatory cells are indicators of a derailed b cell response in lupus, which could be modified by targeting il-21r. Int. J. Mol. Sci., 23.

5. Kuca-Warnawin, E., Plebańczyk, M., Ciechomska, M., Olesińska, M., Szczęsny, P., and Kontny, E. (2022). Impact of adipose-derived mesenchymal stem cells (ascs) of rheumatic disease patients on t helper cell differentiation. Int. J. Mol. Sci., 23.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prioritizing drug targets in systemic lupus erythematosus from a genetic perspective: a druggable genome-wide Mendelian randomization study;Clinical Rheumatology;2024-07-13

2. Immunoregulatory Roles of Osteopontin in Diseases;Nutrients;2024-01-20